BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2491609)

  • 1. Induction of microsomal antigen and comparison with histologic localization of HLA-DR in Graves' thyroid tissue.
    Roman SH; Goldsmith NK; Leiderman IZ; Davies TF
    Autoimmunity; 1989; 2(3):253-63. PubMed ID: 2491609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid microsomal antigen in Graves' thyroid is not different from that in normal thyroid.
    Hamada N; Degroot LJ; Portmann L; Yamakawa J; Noh J; Okamoto Y; Ohno M; Ito K; Morii H
    Endocrinol Jpn; 1991 Oct; 38(5):471-8. PubMed ID: 1843266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-polarized cell surface expression of HLA-A,B,C and HLA-DR antigens in Graves' thyroid follicle cells.
    Mölne J; Nilsson M; Jansson S; Hansson G; Ericson LE
    Autoimmunity; 1991; 10(3):189-99. PubMed ID: 1756224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice.
    Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R
    Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood T lymphocyte sensitization to thyroid microsomal antigen from patients with Graves' disease negative for circulating anti-thyroid microsomal antibodies.
    Matsubayashi S; Sakatsume Y; Kasuga Y; Akasu F; Tamai H; Volpé R
    Clin Invest Med; 1990 Dec; 13(6):339-42. PubMed ID: 2078913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of supernatants of peripheral blood mononuclear cells stimulated by thyroid microsomal antigen on thyrocyte HLA-dr expression in vitro.
    Matsubayashi S; Sakatsume Y; Kasuga Y; Tamai H; Volpé R
    Autoimmunity; 1990; 8(2):91-6. PubMed ID: 2129496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of FK-506 on xenografted human Graves' thyroid tissue is severe combined immunodeficient mice.
    Yoshikawa N; Arreaza G; Mukuta T; Resetkova E; Miller N; Jamieson C; Nishikawa M; Inada M; Volpé R
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):31-9. PubMed ID: 7519528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence of RFD-1 positive dendritic cells to the basal surface of thyroid follicular cells in Graves' disease.
    Mölne J; Jansson S; Ericson LE; Nilsson M
    Autoimmunity; 1994; 17(1):59-71. PubMed ID: 8025214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is human leukocyte antigen-DR and intercellular adhesion molecule-1 expression on human thyrocytes constitutive in papillary thyroid cancer? Comparative studies in human thyroid xenografts in severe combined immunodeficient and nude mice.
    Kawai K; Resetkova E; Enomoto T; Fornasier V; Volpé R
    J Clin Endocrinol Metab; 1998 Jan; 83(1):157-64. PubMed ID: 9435434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical studies using immunized Guinea pig sera with features of anti-human thyroid, eye and skeletal antibody and Graves' sera.
    Molnár I; Szombathy Z; Kovács I; Szentmiklósi AJ
    J Clin Immunol; 2007 Mar; 27(2):172-80. PubMed ID: 17243008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithyroid drugs inhibit in vivo HLA-DR expression in thyroid follicular cells in Graves' disease.
    Zantut-Wittmann DE; Tambascia MA; da Silva Trevisan MA; Pinto GA; Vassallo J
    Thyroid; 2001 Jun; 11(6):575-80. PubMed ID: 11442005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition.
    Ludgate ME; Ratanachaiyavong S; Weetman AP; Hall R; McGregor AM
    J Clin Endocrinol Metab; 1985 Jan; 60(1):98-102. PubMed ID: 3871093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
    Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
    Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice.
    Yoshikawa N; Arreaza G; Morita T; Mukuta T; Resetkova E; Akasu F; Miller N; Jamieson C; Volpé R
    J Clin Endocrinol Metab; 1994 Feb; 78(2):367-74. PubMed ID: 8106624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma has a protective role against thyroid-specific autoantibody production in severe combined immunodeficient (SCID) mice xenografted with Graves' thyroid tissue.
    Yoshikawa N; Mori S; Tokoro T; Ikehara S; Kumazawa H; Yamashita T; Nishikawa M; Inada M
    Thyroid; 1996 Oct; 6(5):437-43. PubMed ID: 8936668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increment in the Ta1+ cells in the peripheral blood and thyroid tissue of patients with Graves' disease.
    Eguchi K; Ueki Y; Shimomura C; Otsubo T; Nakao H; Migita K; Kawakami A; Matsunaga M; Tezuka H; Ishikawa N
    J Immunol; 1989 Jun; 142(12):4233-40. PubMed ID: 2542405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis.
    Bermann M; Magee M; Koenig RJ; Kaplan MM; Arscott P; Maastricht J; Johnson J; Baker JR
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1098-101. PubMed ID: 8408460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
    Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders.
    Mariotti S; Chiovato L; Vitti P; Marcocci C; Fenzi GF; Del Prete GF; Tiri A; Romagnani S; Ricci M; Pinchera A
    Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 2):S73-84. PubMed ID: 2642770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice.
    Resetkova E; Kawai K; Enomoto T; Arreaza G; Togun R; Foy TM; Noelle RJ; Volpé R
    Thyroid; 1996 Aug; 6(4):267-73. PubMed ID: 8875745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.